Infections caused by carbapenem-resistant Klebsiella pneumoniae (CRKP) pose a huge health challenge worldwide. The aim of this study was to evaluate the incidence of polymyxin resistance in clinical CRKP isolates in China and to characterize the molecular mechanisms underlying these polymyxin-resistant CRKP (PR-CRKP) isolates. A total of 493 CRKP clinical isolates from patients were collected from six tertiary-care hospitals in China during 2017-2018. Minimum inhibitory concentrations of polymyxin B and colistin were determined using the broth microdilution method. PR-CRKP isolates were identified and subjected to whole-genome sequencing. Quantitative real-time PCR and structural modelling analysis were also performed. We observed a 2.2% (11/493) polymyxin resistance rate in this multicentre cohort. Polymyxin B MICs ranged from 4 to 64 μg/mL and colistin MICs ranged from 8 to 128 μg/mL in 11 PR-CRKP isolates. Key genetic variations identified in PR-CRKP isolates involved eight disruptions (seven insertional inactivation by an insertion sequence [IS] element, one frameshift deletion) in mgrB, and three missense mutations in pmrA, pmrB, and phoP. ISKpn26 was the predominant IS (4/7), and three of these occurred in nucleotide position 74 in the mgrB gene. In addition, we reported a novel mutation S62R in pmrB that may confer polymyxin resistance in K. pneumoniae. Our findings highlight the multifaceted molecular mechanisms of polymyxin resistance in CRKP.
24 May 2019 in Molecular Genetics & Genomic Medicine
Background: Next‐generation sequencing (NGS) has been widely used in both clinics and research. It has become the most powerful tool for diagnosing genetic disorders and investigating disease etiology through the discovery of genetic variants. Variants identified by NGS are stored in variant call format (VCF) files. However, querying and filtering VCF files are extremely difficult for researchers without programming skills. Furthermore, as the mutation data are increasing exponentially, there is an urgent need to develop tools to manage these variant data in a centralized way.Methods: The VCF‐Server was developed as a web‐based visualization tool to support the interactive analysis of genetic variant data. It allows researchers and medical geneticists to manage, annotate, filter, query, and export variants in a fast and effective way.Results: In this study, we developed the VCF‐Server, a powerful and easily accessible tool for researchers and medical geneticists to perform variant analysis. Users can query VCFs, annotate, and filter variants without knowing programming code. Once the VCF file is uploaded, VCF‐Server allows users to annotate the VCF with commonly used databases or user‐defined variant annotations (including variant blacklist and whitelist). Variant information in the VCF is shown visually via the interactive graphical interface. Users can filter the variants with flexible filtering rules, and the prioritized variants can be exported locally for further analysis. As VCF‐Server adopts a web file system, files in the VCF‐Server can be stored and managed in a centralized way. Moreover, VCF‐Server allows direct web‐based analysis (accessible through either desktop computers or mobile devices) as well as local deployment.Conclusions: With an easy‐to‐use graphical interface, VCF‐Server allows researchers with little bioinformatics background to explore and mine mutation data, which may broaden the application of NGS technology in clinics and research. The tool is freely available for use at https://www.diseasegps.org/VCF-Server?lan = eng.
Globally disseminated carbapenem-resistant Enterobacterales is an urgent threat to public health. The most common carbapenem resistance mechanism is the production of carbapenemases.
Carbapenem-resistant Klebsiella pneumoniae (CRKP) has disseminated worldwide and can cause life-threatening infections, including pneumonia, bloodstream infections, urinary tract infections, intraabdominal infection, liver abscess, and meningitis. CRKP infection is the leading cause of high mortality in hospitals.
Klebsiella pneumoniae is a significant human pathogen in both hospital and community settings; however, limited data exist regarding its prevalence in district-level hospitals. This study aimed to characterize the drug resistance mechanisms, molecular epidemiology, and virulence profiles of K. pneumoniae in a district hospital in Chengdu, China. A total of 114 clinical isolates were collected between May 2023 and May 2024. Antimicrobial susceptibility testing using the broth microdilution method revealed resistance rates of 14.0–21.1% to third-generation cephalosporins, and 5.3% to carbapenems. Whole-genome sequencing showed that 18.4% (21/114) of the isolates carried ESBL genes, with blaCTX–M–15 ( n = 7) being the most common. Six carbapenem-resistant isolates were identified, of which four produced carbapenemases: three harbored blaNDM–5 and one carried blaKPC–2 . MLST analysis identified 67 sequence types, with ST23 ( n = 9) being the most prevalent. The 21 ESBL-producing isolates were distributed across 15 sequence types, while the six carbapenem-resistant isolates were assigned to four distinct sequence types. Virulence-associated genes were detected at high frequencies, including ybt (39.5%), clb (12.3%), iuc (50.0%), iro (60.5%), rmpA (59.6%), and rmpA2 (36.8%), and were commonly found in ST23 ( n = 9), ST412 ( n = 6), ST25 ( n = 5), ST268 ( n = 5), and ST375 ( n = 4). In conclusion, K. pneumoniae isolates from this district hospital showed low resistance rates but a worrying high prevalence of virulence genes. This highlights the urgent need for continuous surveillance and early intervention strategies to prevent the emergence of highly virulent and multidrug-resistant strains in healthcare settings.